Today 33 European academic partners and 5 pharmaceutical companies are launching a new project, COMBACTE-MAGNET, under the IMI antimicrobial resistance research programme New Drugs 4 Bad Bugs (ND4BB). ND4BB has been launched to stimulate antibiotic development in…
Source: COMBACTE-MAGNET project launched to study new treatment options for infections caused by MDR-GNB
Wednesday, February 4, 2015
COMBACTE-MAGNET project launched to study new treatment options for infections caused by MDR-GNB
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment